Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-014235

Chief Operating Officer sold 42,500 shares at $18.98 ($806,650)

  • Chief Operating Officer acquired 42,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-02-25 Option exercise +42,500 $2.01 $85,425 687,106 D
GIVEN BRUCE D Chief Operating Officer 2019-02-25 Sale −42,500 $18.98 $806,650 644,606 D
Derivatives
GIVEN BRUCE D Chief Operating Officer 2019-02-25 Option exercise · Stock Option (right to buy) −42,500 392,500 D
Open-market sales · 42,500 sh · avg $18.98 · $806,650
Loading xslF345X03/doc4.xml…